Related Experiment Video
Updated: Apr 12, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study
Marc Maegele1, Max Zinser, Christoph Schlimp
1From the Department of Traumatology, Orthopedic Surgery and Sports Medicine (M.M.), and Department of Plastic and Reconstructive Surgery (M.Z.), Burn Center, Cologne-Merheim Medical Center (CMMC), and Institute for Research in Operative Medicine (IFOM) (M.M.), University of Witten/Herdecke, Cologne, Germany; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology (C.S., H.S.), AUVA Research Center, Vienna; Department of Anaesthesiology and Intensive Care (C.S., H.S.), AUVA Trauma Hospital Klagenfurt, Klagenfurt; Department of Anaesthesiology and Intensive Care (C.S.), AUVA Trauma Center Salzburg, Salzburg; and University Clinic for General and Surgical Intensive Care (D.F.), Medical University Innsbruck, Innsbruck, Austria.
No abstract available in PubMed .
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

